Trial Profile
Pharmacodynamic effects of ticagrelor in patients with acute coronary syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes; Coronary artery disease
- Focus Pharmacodynamics
- 30 Dec 2016 New trial record
- 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association